Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
- Values for Accuhaler and Evohaler are from the Carbon Trust 2017 Carbon Footprint Report
- Values for Relvar are from the Ellipta Carbon Trust 2020 Carbon Footprint Report
- Where more than one dose strength pack is available for a particular product, the carbon footprint was specifically calculated for the pack with the highest demand in the year prior to the carbon footprint report, as shown in the graph above
Conscious about carbon? Choose Accuhaler, reduce the NHS' carbon footprint, go green!
Scroll down to learn more
The GSK DPI Portfolio for Asthma has a significantly lower carbon footprint than the MDI portfolio
The GSK DPI portfolio for asthma includes Ventolin (salbutamol) Accuhaler, Flixotide (fluticasone propionate) Accuhaler, Relvar (fluticasone furoate/vilanterol) Ellipta and Seretide (salmeterol/fluticasone propionate) Accuhaler
Indicative net rounded carbon emissions per pack
Product indications and dosing regimens are different. Please consult product SmPCs before prescribing
Consult product SmPCs for dosing regimens for different salbutamol dose strengths
- 1IQVIA prescribed volume MAT April 2022
- Salamol and Easyhaler Salbutamol Indicative Carbon Footprint are from Prescqipp Inhaler Carbon Footprint Data v2.15 (accessed June 2022)
- Values for Accuhaler and Evohaler are from the Carbon Trust 2017 Carbon Footprint Report
-
Click here to view low dose alternatives
Low dose for adult asthma
Indicative carbon footprint per 28 days![Bar chart showing the carbon footprint of Flixotide and other ICS brands at low dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 100mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 100mcg 200 dose (2 puffs bd) 0.78kgCO2e, Pulmicort Turbohaler 200mcg 100 dose (1 puff bd) 0.78kgCO2e, Clenil Inhaler 100mcg 200 dose (2 puffs bd) 9.27 kgCO2e and Flixotide Evohaler 50mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 100mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs]( "Bar chart showing the carbon footprint of Flixotide and other ICS brands at low dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 100mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 100mcg 200 dose (2 puffs bd) 0.78kgCO2e, Pulmicort Turbohaler 200mcg 100 dose (1 puff bd) 0.78kgCO2e, Clenil Inhaler 100mcg 200 dose (2 puffs bd) 9.27 kgCO2e and Flixotide Evohaler 50mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 100mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs")
![Bar chart showing the carbon footprint of Flixotide and other ICS brands at low dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 100mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 100mcg 200 dose (2 puffs bd) 0.78kgCO2e, Pulmicort Turbohaler 200mcg 100 dose (1 puff bd) 0.78kgCO2e, Clenil Inhaler 100mcg 200 dose (2 puffs bd) 9.27 kgCO2e and Flixotide Evohaler 50mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 100mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs]( "Bar chart showing the carbon footprint of Flixotide and other ICS brands at low dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 100mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 100mcg 200 dose (2 puffs bd) 0.78kgCO2e, Pulmicort Turbohaler 200mcg 100 dose (1 puff bd) 0.78kgCO2e, Clenil Inhaler 100mcg 200 dose (2 puffs bd) 9.27 kgCO2e and Flixotide Evohaler 50mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 100mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs")
-
Click here to view medium dose alternatives
Medium dose for adult asthma
Indicative carbon footprint per 28 days![Bar chart showing the carbon footprint of Flixotide and other ICS brands at medium dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 250mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 200mcg 100 dose (2 puffs bd) 1.57kgCO2e, Pulmicort Turbohaler 400mcg 50 dose (1 puff bd) 1.90kgCO2e, Clenil Inhaler 200mcg 200 dose (2 puffs bd) 9.14 kgCO2e and Flixotide Evohaler 125mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 250mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs]( "Bar chart showing the carbon footprint of Flixotide and other ICS brands at medium dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 250mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 200mcg 100 dose (2 puffs bd) 1.57kgCO2e, Pulmicort Turbohaler 400mcg 50 dose (1 puff bd) 1.90kgCO2e, Clenil Inhaler 200mcg 200 dose (2 puffs bd) 9.14 kgCO2e and Flixotide Evohaler 125mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 250mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs")
![Bar chart showing the carbon footprint of Flixotide and other ICS brands at medium dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 250mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 200mcg 100 dose (2 puffs bd) 1.57kgCO2e, Pulmicort Turbohaler 400mcg 50 dose (1 puff bd) 1.90kgCO2e, Clenil Inhaler 200mcg 200 dose (2 puffs bd) 9.14 kgCO2e and Flixotide Evohaler 125mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 250mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs]( "Bar chart showing the carbon footprint of Flixotide and other ICS brands at medium dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 250mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 200mcg 100 dose (2 puffs bd) 1.57kgCO2e, Pulmicort Turbohaler 400mcg 50 dose (1 puff bd) 1.90kgCO2e, Clenil Inhaler 200mcg 200 dose (2 puffs bd) 9.14 kgCO2e and Flixotide Evohaler 125mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 250mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs")
-
Click here to view high dose alternatives
High dose for adult asthma
Indicative carbon footprint per 28 days![Bar chart showing the carbon footprint of Flixotide and other ICS brands at high dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 500mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 400mcg 50 dose (2 puffs bd) 3.81kgCO2e, Clenil Inhaler 250mcg 200 dose (2 puffs bd) 9.01 kgCO2e, Clenil Inhaler 250mcg 200 dose (4 puffs bd) 18.02kgCO2e and Flixotide Evohaler 250mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 500mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs]( "Bar chart showing the carbon footprint of Flixotide and other ICS brands at high dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 500mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 400mcg 50 dose (2 puffs bd) 3.81kgCO2e, Clenil Inhaler 250mcg 200 dose (2 puffs bd) 9.01 kgCO2e, Clenil Inhaler 250mcg 200 dose (4 puffs bd) 18.02kgCO2e and Flixotide Evohaler 250mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 500mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs")
![Bar chart showing the carbon footprint of Flixotide and other ICS brands at high dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 500mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 400mcg 50 dose (2 puffs bd) 3.81kgCO2e, Clenil Inhaler 250mcg 200 dose (2 puffs bd) 9.01 kgCO2e, Clenil Inhaler 250mcg 200 dose (4 puffs bd) 18.02kgCO2e and Flixotide Evohaler 250mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 500mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs]( "Bar chart showing the carbon footprint of Flixotide and other ICS brands at high dose for adult asthma, carbon footprints are shown in kgCO2e. There is one bar per pack with the following carbon footprints displayed, from left to right, Flixotide Accuhaler 500mcg 60 dose (1 puff bd) 0.79kgCO2e, Pulmicort Turbohaler 400mcg 50 dose (2 puffs bd) 3.81kgCO2e, Clenil Inhaler 250mcg 200 dose (2 puffs bd) 9.01 kgCO2e, Clenil Inhaler 250mcg 200 dose (4 puffs bd) 18.02kgCO2e and Flixotide Evohaler 250mcg 120 dose (2 puffs bd) 17.73kgCO2e. At the top of the Flixotide Accuhaler 500mcg bar there is a small picture of a Flixotide Accuhaler. There is an asterisk associated with each of the Flixotide bars leading to a note under the graphs")
- 1IQVIA prescribed data prescribed volume MAT April 2022
- Categorisation and dosing taken from BTS/SIGN Guideline 2019 Table 12
- Please consult product SmPCs for specific indications and dosing regimens
- *Flixotide Evohaler 250mcg and Flixotide Accuhaler 500mcg (the packs for each device with the highest demand in 2016) had the carbon footprint calculated. This is indicative for all other strengths in the respective device's pack range
- Indicative carbon footprint per 28 days for Clenil and Pulmicort calculated using dose from BTS/SIGN Guideline 2019 Table 12 and carbon footprint from Prescqipp Inhaler Carbon Footprint Data v2.15 (accessed June 2022)
- The NHS has set an ambitious goal to be the worlds first net zero national health service with clear goals to achieve this before 2040.2
FIND OUT MORE
- GSK aim to achieve net zero impact on climate and a net positive impact on nature by 2030
FIND OUT MORE
Choose Accuhaler, reduce carbon
References
- IQVIA prescribed data prescribed volume MAT April 2022
- https://www.england.nhs.uk/greenernhs/a-net-zero-nhs/ (accessed June 2022)
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441
© 2022 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.
Third party trade marks are the property of their respective owners
July 2022 | PM-GB-CEP-WCNT-220001 (V1.0)
